Kinetics of CAR-T cells and immunological profile after tisagenlecleucel therapy

Richert-Przygońska, Monika; Stankiewicz, Joanna; Czyżewski, Krzysztof; Dębski, Robert; Kubicka, Małgorzata; Kuryło-Rafińska, Beata; Majk, Agnieszka; Dembna, Ewa; Ledziński, Łukasz; Marquardt, Ewa; Gągola, Katarzyna; Styczyński, Jan

doi:10.5603/ahp.a2023.0031

Acta Haematol Pol.

2023

DOI: 10.5603/ahp.a2023.0031

|View full text |Cite

Kinetics of CAR-T cells and immunological profile after tisagenlecleucel therapy

Monika Richert-Przygońska,

Joanna Stankiewicz,

Krzysztof Czyżewski

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therapy with CAR-T represents a new therapeutic possibility in patients with advanced refractory or relapsing ALL or non-Hodgkin lymphoma (NHL) [3][4][5][6].…”

mentioning

confidence: 99%

Very late relapse of ALL after 14 years: treatment with CAR-T cells

Richert-Przygońska,

Czyżewski,

Dębski

et al. 2023

Acta Haematol Pol.

View full text Add to dashboard Cite

“…Therapy with CAR-T represents a new therapeutic possibility in patients with advanced refractory or relapsing ALL or non-Hodgkin lymphoma (NHL) [3][4][5][6].…”

mentioning

confidence: 99%

Very late relapse of ALL after 14 years: treatment with CAR-T cells

Richert-Przygońska,

Czyżewski,

Dębski

et al. 2023

Acta Haematol Pol.

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Kinetics of CAR-T cells and immunological profile after tisagenlecleucel therapy

Cited by 1 publication

References 10 publications

Very late relapse of ALL after 14 years: treatment with CAR-T cells

Very late relapse of ALL after 14 years: treatment with CAR-T cells

Contact Info

Product

Resources

About